SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-22-062344
Filing Date
2022-03-02
Accepted
2022-03-02 08:29:21
Documents
6
Effectiveness Date
2022-03-02

Document Format Files

Seq Description Document Type Size
1 S-3ASR d46320ds3asr.htm S-3ASR 259320
2 EX-5.1 d46320dex51.htm EX-5.1 16549
3 EX-23.1 d46320dex231.htm EX-23.1 1350
4 EX-FILING FEES d46320dexfilingfees.htm EX-FILING FEES 66549
5 GRAPHIC g46320g00a01.jpg GRAPHIC 69858
6 GRAPHIC g46320g06v80.jpg GRAPHIC 4796
  Complete submission text file 0001193125-22-062344.txt   448184
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-263208 | Film No.: 22701448
SIC: 2834 Pharmaceutical Preparations